Log in
APRINOIA Therapeutics
Contact
View in org chart
Mark S. Shearman
CEO
Masaomi Miyamoto
EVP of R&D & Operations
Tzu-Chen Yen
General Manager
Lili Zhang
SVP, Head of Preclinical Development
Bradford A. Navia
Chief Medical Officer
+ 4 more
Current role
